Results 91 to 100 of about 1,438,405 (173)
Raynaud’s Phenomenon and Ulcers
Raynaud’s phenomenon (RP) is a common condition which can occur either primary (idiopathic) or secondary to a wide range of conditions or drug therapies.
Michael Hughes +5 more
core +1 more source
Aims The aim of this study was to compare the efficacy of a corticosteroid injection for the treatment of carpal tunnel syndrome (CTS) in patients with and without Raynaud’s phenomenon.
노영학
core +2 more sources
Review of Raynaud’s phenomenon: pathomechanisms, diagnosis and treatment [PDF]
Introduction: Raynaud’s phenomenon (RP) is a quite common but often unrecognised vasospastic condition of the peripheral vessels. This may happen after exposure to the cold, stress, vibrations or a wide range of medical conditions.
Turek, Aleksandra +7 more
core
Arsenic is commonly known to be associated with squamous cell carcinoma. Among the lesser known associations is basal cell carcinoma and even rarer is its effect on blood vessels causing peripheral vascular disease.
Rathin Hazra +4 more
core +1 more source
Glomus Tumor Presenting as Raynaud's Phenomenon
Glomus tumors are rare tumors that often include hands and feet; they present characteristically with paroxysmal pain, exquisite point tenderness, and cold sensitivity.
M. H. Abdelrahman, M. Hammoudeh
doaj +1 more source
Current trends in definition and treatment of Raynaud’s phenomenon
The review is Dedicated to the analysis of modern literature on the definition, classification and diagnostics of Raynaud’s phenomenon, describes the main causes of secondary RP, clinical manifestations of RP, the importance of capillaroscopy in the ...
I. R. Gaisin, Z. R. Bagautdinova
core
Evidence-based management of Raynaud’s phenomenon
Raynaud’s phenomenon (RP) is relevant to the rheumatologist because it may signify an underlying connective tissue disease and also because it can be very challenging to treat, especially when it has progressed to digital ulceration or critical ...
Ariane L. Herrick
core +1 more source
Raynaud's phenomenon during treatment with lisdexamfetamine: risk of cerebral vasospasm?
Lisdexamfetamine, a prodrug used to treat Attention Deficit/Hyperactivity Disorder in children, adolescents, and adults, is an inactive substance that is converted into its active form (dextroamphetamine) after being metabolized.
Rubens Pitliuk +1 more
doaj +1 more source
Prevalence, Incidence, and Mortality of Raynaud’s phenomenon, Sjögren’s syndrome, and scleroderma: an umbrella review of systematic reviews [PDF]
Objectives: To comprehensively review systematic reviews of prevalence, incidence, and mortality of Raynaud’s, Sjögren’s, and Scleroderma, and to identify any research gaps.Methods: An umbrella review of English language systematic reviews was undertaken
Chen, Anthony +4 more
core +1 more source
Prothrombotic polymorphisms in patients with Raynaud’s phenomenon and migraine
We have investigated the prevalence and possible association of inherited prothrombotic risk factors in patients with primary Raynaud’s phenomenon (PRP) and migraine.
Takáts, A.T. +4 more
core +1 more source

